Search Results

The Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation (BEAT-AF) treatment project is an initiative funded by the European Commission from the European Union’s Horizon 2020 research and innovation programme, and managed under the European Health and Digital Executive Agency (grant number 945125).1,2 The study was also partly funded by IHU LIRYC ANR-10-IAHU-04. This pioneering 5-year programme commenced on […]

Catheter ablation has emerged as an effective strategy for the treatment of atrial fibrillation (AF), even becoming a first-line option for selected patients.1 Pulmonary vein isolation (PVI) is the cornerstone of this procedure. Ablation beyond PVI is often practised, but scientific evidence from randomized clinical trials is still controversial.2–8 Point-by-point radiofrequency (RF) ablation has been, by […]

Atrial fibrillation (AF) is the most common type of treated cardiac arrhythmia. The prevalence of the condition increases with age, and it presents with a wide spectrum of symptoms and severity. As the population ages, particularly in developed countries, the burden of AF increases.1 Compared with sinus rhythm, AF is also associated with an increased incidence of […]

Petr Neuzil (Cardiocentre, Na Homolce Hospital, Prague) talks about the latest technologies currently being researched in the treatment of arrhythmia. New technologies and innovations such as RF balloons (such as the Biosense Webster; Helios), electroporation and diamond tip RF catheters aim to speed up the application time of the procedure. The electrophysiology (EP) field is […]

Introduction: Pulsed field ablation (PFA) is a novel, non-thermal, atrial fibrillation (AF) ablation technique, in which delivery of millisecond electrical pulses generates pores in cell membranes, leading to its disruption (electroporation). PFA has demonstrated high selectivity for cardiomyocytes, thus reducing the risk of collateral extracardiac tissue damage often associated with thermal ablation methods. Both preclinical […]

Highlights Failure to target and deliver durable radiofrequency lesions to all functionally critical areas has been identified as an important cause of ventricular tachycardia recurrence and is particularly challenging in deep midmyocardial or very extensive substrate where point-by-point radiofrequency ablation becomes impractical. Alternative approaches have been described to: improve radiofrequency energy delivery to the tissue […]

This last issue of European Journal of Arrhythmia & Electrophysiology highlights advancements in medical technology and cardiac health. Claire Pesterfield, Claire Guest and Simone Brainch discuss the role of medical detection dogs in managing postural tachycardia syndrome. Pierre Jais discusses novel electroporation techniques in atrial fibrillation treatment in a cutting-edge trial. Finally, Kavinsky et al. […]

It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served as a platform for groundbreaking research, clinical insights and news that have helped shape the […]